info@ceoworld.biz
Sunday, November 17, 2024

Banking and Finance

Banking and Finance

SAB Biotherapeutics CFO Michael King to Depart for CEO Role at Oncology Firm

SAB Biotherapeutics (NASDAQ: SABS), a clinical-stage biopharmaceutical company, announced that Chief Financial Officer Michael King will leave his position on June 4 to become CEO of a private oncology firm. King will continue to advise SAB until the end of the year. The Board of Directors has initiated a search...
1 43 44 45 46 47 219
Page 45 of 219